HomeInsights52 Week Low Stocks

Dr Reddys Laboratories Ltd 52 Week Low

Dr Reddys Laboratories Ltd 52 Week Low

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

7.8 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

YEARLOW

₹ 1074.35

Last updated on: Nov 07, 2024

Key Highlights

  • The 52 Week Low of Dr Reddys Laboratories Ltd is ₹ 1074 as of 07 Nov 24.

Company Fundamentals for Dr Reddys Laboratories Ltd

No data available

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241287.15
06 Nov 20241303
05 Nov 20241272.55
04 Nov 20241267.95
01 Nov 20241258.55
31 Oct 20241274.25
30 Oct 20241250.2
29 Oct 20241275.1
28 Oct 20241312.4
25 Oct 20241302.83

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories Ltd spurts 2.25%

Dr Reddys Laboratories Ltd is up for a third straight session in a row. The stock is quoti...

Read more

06 Nov 202413:05

News

Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore

Total revenue from operations stood at Rs 8,038.2 crore in Q2 FY25, up 16.45% YoY, primari...

Read more

05 Nov 202417:35

News

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the...

Read more

08 Oct 202418:16

News

Dr Reddys announces incorporation of new step-down subsidiary in Denmark

Dr. Reddy's Laboratories SA, Switzerland, (DRSA) a wholly owned subsidiary of  Dr Reddys ...

Read more

05 Oct 202411:37

News

Dr Reddys acquires Haleon plc brands in NRT category

Dr Reddys Laboratories announced that its wholly owned subsidiary, Dr. Reddy's Laboratorie...

Read more

30 Sep 202417:31

News

Dr Reddys Laboratories schedules board meeting

Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 5 N...

Read more

23 Sep 202410:11

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Dr Reddys Laboratories Ltd

Why is it important to track the 52-week low of Dr Reddys Laboratories Ltd stocks?

Investors should monitor the 52-week low of Dr Reddys Laboratories Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Dr Reddys Laboratories Ltd stocks hitting a 52-week low?

Factors leading to Dr Reddys Laboratories Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Dr Reddys Laboratories Ltd stocks when they hit a 52-week low?

Buying Dr Reddys Laboratories Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Dr Reddys Laboratories Ltd stocks?

Investors should monitor the 52-week low of Dr Reddys Laboratories Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Dr Reddys Laboratories Ltd stock at their 52-week low?

An investor can analyze the reasons for the Dr Reddys Laboratories Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Dr Reddys Laboratories Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Dr Reddys Laboratories Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Dr Reddys Laboratories Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*